Multimorbidity, Polypharmacy and Cognitive Assessment Among a Sample of Elderly People in Erbil
DOI:
https://doi.org/10.56056/Keywords:
Cognitive impairments, Multimorbidity, Mini-mental status examination, PolypharmacyAbstract
Background and objectives: As life expectancy increases and the world's population ages, multimorbidity is becoming more widespread globally, the study aims to evaluate the degree of cognitive impairment and the frequency of polypharmacy and multi-morbidity in elderly patients, as well as the association of cognitive impairment with sociodemographic background, adverse drug reactions, with multimorbidity and polypharmacy.
Methods: A cross-sectional study was conducted with 165 elderly patients (who visited Rizgari Teaching Hospital and Brayati Family Primary Health Center in Erbil City, from the first of February 2023 till end of September 2023) were enrolled in this study. The questionnaire included basic demographics, medical, and medication history, and a cognitive assessment. The latter was done using the Mini-Mental State Examination.
Results: The results demonstrated that with increasing age, cognitive impairment became more severe (p-value = 0.005). There was more severe cognitive impairment among females (20.2%) compared with males (3.7%). (p-value <0.001). The severity of cognitive impairment was improved among those with higher levels of education. Of those with low socioeconomic status, 35% had severe cognitive impairment in comparison to those with medium socioeconomic status which was 4.8% (p-value <0.001). Of the participants, 92.7% had multimorbidity with no significant association with cognitive impairment (P-value = 0.625). Around one-quarter (24.8%) of participants took 5 or more medications. Some commonly observed adverse drug reactions were observed like: constipation, falling, delirium, difficulty sleeping, urine retention, and vertigo with significant association with cognitive impairment (p-value = 0.021).
Conclusion: In this study, it was found that severe cognitive impairment increases with age among the elderly in Erbil, with females and illiterate individuals more affected.
Downloads
References
1. Caçador C, Teixeira-Lemos E, Oliveira J, Pinheiro J, Teixeira-Lemos L, Ramos F. The Prevalence of Polypharmacy and Potentially Inappropriate Medications and Its Relationship with
Cognitive Status in Portuguese Institutionalized Older Adults: A Cross-Sectional Study. Int J Environ Res Public Health. 2022 Feb 24;19(5):2637. doi: 10.3390/ijerph19052637/
2. Assari S, Wisseh C, Saqib M, Bazargan M. Polypharmacy Is Associated with Lower Memory Function in African American Older Adults. Brain Sci. 2020 Jan 16;10(1):49.
3. Aljeaidi MS, Tan EC. The association between polypharmacy and cognitive ability in older adults: A national cohort study. Res Soc Adm Pharm. 2022 Mar;18(3):2505–9. Doi: 10.1016/j.sapharm.2021.04.018.
4. Rodrigues D, Teresa Herdeiro M, Figueiras A, Coutinho P, Roque F. Elderly and Polypharmacy: Physiological and Cognitive Changes. In: Palermo S, editor. Frailty in the Elderly - Understanding and Managing Complexity. IntechOpen; 2021. Available from: https://www.intechopen.com/books/frailty-in-the-elderly-understanding-and-managing-complexity/elderly-and-polypharmacy-physiological-and-cognitive-changes/
5. Chippa V, Roy K. Geriatric Cognitive Decline and Polypharmacy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK574575/
6. Soleimani R, Shokrgozar S, Fallahi M, Kafi H, Kiani M. An investigation into the prevalence of cognitive impairment and the performance of older adults in Guilan province. J Med Life. 2018 Jul-Sep;11(3):247-253. doi: 10.25122/jml-2018-0017/
7. Shabu SA, Al-Tawil NG. Prevalence of childhood obesity among a sample of basic education school children in Erbil city. MEJFM. 2010;10(10):4-13. Available from: https://platform.almanhal.com/Files/2/1866/
8. World Population Prospects. The 2017 Revision. Key Findings and Advance Tables. United Nations. New York, 2017. https://population.un.org/wpp/Publications/Files/WPP2017_KeyFindings.pdf
9. Al-Nuaimi A, Fadil J. Cognitive Impairment Among Old ages, Iraqi J. Med. Sci 2023; 36(2), 133-139. Available from: https://www.iasj.net/iasj/article/279150(IASJ)/
10. Kanagaratnam L, Dramé M, Trenque T, Oubaya N, Nazeyrollas P, Novella JL, et al. Adverse drug reactions in elderly patients with cognitive disorders: A systematic review. Maturitas. 2016 Mar; 85:56–63.
11. Redha AO, Aziz TA. Problems associated with polypharmacy in elderly patients in Kurdistan region/ Iraq. World J Pharm Sci 2015; 3(4): 772-778.
12- Wittenberg GF, McKay MA, O’Connor M. Exploring the Association between Multimorbidity and Cognitive Impairment in Older Adults Living in the Community: A Review of the Literature. Home Health Care Manag Pract. 2022 Feb;34(1):52–62.
https://doi.org/10.1177/10848223211030468/
13- Al Harkan KS, Al dhawyan AF, Bahamdan AS, Alqurashi YD, Aldulijan FA, Alsamin SI, et al. Association between multimorbidity and cognitive decline in the elderly population of the Eastern Province, Saudi Arabia. J Fam Community Med. 2024 Apr;31(2):99–106. Doi: 10.4103/jfcm.jfcm-268-23/
14- Argas-González JC, Stranges S, Speechley MR, Daley MJ, Were J, Sharma I, et al. The Association between Multimorbidity and Cognitive Decline: A Systematic Review. Western University, London, Canada; Alzheimer’s Dement. 2022;18(11): e067769.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Didan Jassim Muhamed, Ali Shakir Dauod, Rachel Elaine Dunham
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
